In a first-of-its-kind study, FDA-Approved Dantrolene, a muscle relaxant, was delivered through the nose to Alzheimer’s lab animals. It eased their Alzheimer’s by providing therapeutic
VIDEO + ARTICLE: An experimental drug produced by Annovis has received its generic name following successful completion of its Phase II trials. Buntanetap is intended
MEDICATION: THE WORLD’S MOST POPULAR DEMENTIA-DRUG IS DONEPEZIL. Donepezil (Brand-name: Aricept®) boosts memory & thinking in Alzheimer’s. More donepezil means more boost – along with
PROGRESS IN THE NEWS – VIDEO & ARTICLE: In the lab, Alzheimer’s was delayed by FDA-approved “Dabigatran” (Pradaxa®), commonly used to clear blood clots. Can
DRUG NEWS: Genentech will showcase the breadth and promise of their Neuroscience Portfolio at the 2019 American Academy of Neurology Annual Meeting. It includes new
MEDICATION VIDEO + ARTICLE: Scientists found drug developed for diabetes “significantly reversed memory loss” in Alzheimer’s mice, through a triple method of action. See why
CLINICAL TRIALS: Find out why researchers think spraying nasal insulin through the nose can improve cognition, memory and daily function in people with Alzheimer’s. Learn
CLINICAL TRIAL NEWS – VIDEO + ARTICLE: Skeptical Alzheimer’s experts expressed surprising optimism regarding Biogen’s BAN-2401 drug. Dr. Ronald Peterson is one of the world’s
TIME MAGAZINE VIDEO: See Peter Wooding and his wife battle Alzheimer’s, 18 months into the Aducanamab Clinical Trial. On FDA’s Fast-Track program, the new vaccine’s
Large, significant improvements in genetically-defined Alzheimer’s patients were seen in a clinical trial for tramiprosate. Learn about the important potential presented by these Phase-3 trial
Sugar, the brain, and Alzheimer’s – just how tight is their connection? Check out this update from Tulane University’s targeted study.
Women face a higher risk of Alzheimer’s. New research shows that low omega-3 levels may be a hidden factor—and boosting intake through diet or supplements could offer protection.
When memory and thinking seem a little off, people tend to avoid getting a diagnosis. Yet early diagnosis allows for early benefits. These include better planning, treatment and therapy. Learn more about the advantages revealed in an important study.
What are the early symptoms of Alzheimer’s? When to get a professional evaluation.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
No spam, only news and updates.
